Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ɛ-Aminocaproic Acid in Spontaneous Intracerebral Hemorrhage
NCT02639819Phase 1Withdrawn
- Sponsor
- UT Health San Antonio
- Start
- Jun 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of aminocaproic acid in intracerebral hemorrhage (ICH), sponsored by UT Health San Antonio. Primary endpoints: Hematoma volume at 24 hours, Lower extremity deep vein thrombosis and 2 more. Planned start Jun 2016; status: withdrawn.
02
Drugs
aminocaproic acid
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT02639819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02639819.